FDA Clears Siemens’ CTs for Low-Dose Lung Cancer Screening

The FDA has provided clearance for Siemens SOMATOM portfolio of CT scanners for low-dose lung cancer screening.

The U.S. FDA has cleared the SOMATOM CT systems by Siemens Healthcare for low-dose lung cancer screening, Siemens announced last week.

All of Siemens new CT scanners, as well as the company’s installed base of non-end-of-support systems use standard low-dose lung protocols already delivered on the scanners, Siemens said in a release. Automated settings in the Siemens’ portfolio, like reducing user variability, and setting an optimum range for scan settings that avoids cut-offs or excessive radiation, optimize the low-dose lung cancer screening workflow, Siemens said.

Siemens has also launched a mobile imaging solution for lung cancer screening aimed for people living in rural areas, the company announced. The mobile SOMATOM Scope CT is a self-powered mobile CT with an on-board diesel generator that is ready to scan “within minutes” of parking and is equipped with a high-speed wireless connection, Siemens said.

The indication for low-dose lung cancer screening is available for the following CT systems: SOMATOM Force, SOMATOM Definition Flash, SOMATOM Definition Edge, SOMATOM Definition AS/AS+, SOMATOM Perspective, SOMATOM Scope, and the SOMATOM Emotion 16.

[[{"type":"media","view_mode":"media_crop","fid":"43954","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_4646017352372","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"4885","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: right;","title":"Image provided courtesy of Siemens Healthcare.","typeof":"foaf:Image"}}]]